Health Care · Life Sciences Tools & Services · US stock · price as of 16 Oct 2026
Key indicators
Price
$1,622.29
52-week range
$1,023.05 – $1,659.70
Market cap
$32.7B
P/E (trailing)
36.6×
EV / EBITDA
29.8×
Free-cash-flow yield
2.6%
Dividend yield
–
Revenue (last 12 months)
$4.1B
Revenue growth (3y a year)
0.9%
Operating margin
28.2%
Return on invested capital
46.4%
Net debt / EBITDA
1.8×
Fair value
Blended fair value$1,192.85 range $1,123 – $1,281
Versus priceOvervalued−27% to fair value
Peer multiples
$1,215.88
Fundamentals-adjusted multiple
$1,084.35
10-year DCF (market-scaled)
$1,278.31
Earnings power value (floor, not blended)
$443.86
Model uncertainty
Medium
X-Ray Score
50/ 100 · High confidence · ahead of 45% of sector peers
Valuation32
Growth33
Profitability75
Financial health58
Dividends–
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
Executive summary
Mettler-Toledo makes precision instruments used to weigh, measure and analyse. Its range covers laboratory balances, pipettes and analytical instruments for research and quality control, industrial weighing and product inspection systems for factories and food producers, and retail weighing equipment. Customers include pharmaceutical and chemical companies, research laboratories, food producers and manufacturers. The group is organised mainly around geographic regions, with operations in Europe, Asia and North America.
The company earns money from instruments and from recurring service, consumables and software that customers need over the life of each device. Revenue was $4.1 billion over the last twelve months, with growth of 0.9% a year across the last three years. The operating margin is 28.2%, and the business earns a profit of 46% on the capital invested in it. Net debt is 1.8 times EBITDA, and no dividend is paid.
StocksXray gives Mettler Toledo International Inc/ an X-Ray Score of 50 out of 100 (high confidence), ahead of 45% of the S&P 500 stocks in its sector. Its strongest lens is profitability (75) and its weakest is valuation (32).
Our fair value blend is $1,192.85 (range $1,123.40 to $1,281.08). At $1,622.29 the stock trades 36% above that blend, so the label is "Overvalued" with medium model uncertainty. Fair value is a range, not a price target.
XStocksXray
Mettler Toledo International Inc/ (MTD)
Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months
FY2021
FY2022
FY2023
FY2024
FY2025
Now
Price
$1,697.21
$1,445.45
$1,212.96
$1,223.68
$1,394.19
$1,622.29
Market cap
$39.8B
$32.8B
$26.7B
$26.1B
$28.8B
$32.7B
P/E
51.8×
37.6×
33.8×
30.2×
33.2×
36.6×
EV / revenue
11.1×
8.9×
7.6×
7.2×
7.7×
8.4×
EV / EBITDA
41.7×
30.9×
27.3×
25.2×
27.7×
29.8×
Price / free cash flow
49.7×
44.5×
31.0×
30.2×
34.0×
37.9×
Free-cash-flow yield
2.0%
2.2%
3.2%
3.3%
2.9%
2.6%
Price / book
232.2×
1,324.5×
–
–
–
2,551.3×
Dividend yield
–
–
–
–
–
–
Fundamentals checklist ● 4 Good · ● 7 Average · ● 5 Bad · each check graded against the sector
Cash quality
Earnings backed by cash−1.9%Bad
Free-cash-flow yield2.6%Bad
Risk models
Altman Z score11.0×Good
Piotroski F-Score6 of 9Average
Growth
EPS growth (3y)3.1%Average
Free-cash-flow growth (3y)4.8%Average
Revenue growth (3y)0.9%Bad
Growth consistency70%Bad
Balance sheet
Current ratio1.1×Bad
Net debt / EBITDA1.8×Average
Interest cover16.8×Average
Valuation
Fair value vs price0.7×Average
EBIT / EV yield3.4%Average
Profitability
Return on invested capital46.4%Good
Operating margin28.2%Good
Gross profitability67.9%Good
XStocksXray
Mettler Toledo International Inc/ (MTD)
Financials US$ millions, from SEC filings; last column is the last twelve months
Income statement
FY21
FY22
FY23
FY24
FY25
LTM
Revenue
3,718
3,920
3,788
3,872
4,026
4,134
Gross profit
2,172
2,308
2,241
2,326
2,391
2,491
Operating income
993
1,126
1,051
1,112
1,117
1,167
Net income
769
873
789
863
869
906
Diluted EPS ($)
32.78
38.41
35.90
40.48
42.05
44.31
Free cash flow
801
738
861
864
849
864
Gross margin
58.4%
58.9%
59.2%
60.1%
59.4%
60.3%
Operating margin
26.7%
28.7%
27.7%
28.7%
27.8%
28.2%
Net margin
20.7%
22.3%
20.8%
22.3%
21.6%
21.9%
Balance sheet
FY21
FY22
FY23
FY24
FY25
LTM
Total assets
3,327
3,492
3,356
3,240
3,713
3,671
Cash
99
96
70
59
67
51
Total debt
1,682
2,015
2,081
2,014
2,152
2,112
Equity
171
25
-150
-127
-24
13
Dividend per share ($)
–
–
–
–
–
–
Revenue and net income US$ billions: navy revenue, teal net income
Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.